Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study

Inclusion Criteria:

• Subjects attending emergency room due to potential HIV exposition of either sex:
• Aged 18 years or more.
• Who have been exposed to non-occupational HIV and who meet the prerequisites for thecurrent recommendations to begin prophylaxis post-exposition with three antiretroviraldrugs.
• Who after being fully informed, give their written consent to participate in the studyand undergo the tests and examinations required.
• Individuals able to do follow up correctly.

Exclusion Criteria:

• Pregnant women or nursing mothers or women trying to conceive during the study period.
• Patients in whom it is known or suspected that the source case has a resistance to oneof the drugs from the study treatment regimens.
• Treatment with drugs that are contraindicated in the study or products that are in theinvestigational phase.
• Allergic reactions or intolerance to the compounds of the study treatment regiments